Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials

BACKGROUND: Triple-Negative Breast Cancer (TNBC) is a lethal subtype of breast cancer with limited treatment options. The purpose of this Network Meta-Analysis (NMA) is to compare the efficacy and safety of inhibitors of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) in tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmakaty, Ibrahim, Abdo, Ruba, Elsabagh, Ahmed, Elsayed, Abdelrahman, Malki, Mohammed Imad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173590/
https://www.ncbi.nlm.nih.gov/pubmed/37170090
http://dx.doi.org/10.1186/s12935-023-02941-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173590/
https://www.ncbi.nlm.nih.gov/pubmed/37170090
http://dx.doi.org/10.1186/s12935-023-02941-7

Ejemplares similares